PDS Biotechnology Corp
PDSB· Nasdaq
PDSBPDS Biotechnology Corp
Filed Mar 31, 2022 · 10-K · 90 days after period end · 0001140361-22-012244
| Metric | Q4 2021 | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$6.32M | -$4.03M | -$4.18M | -$1.82M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 31, 2022 · 90 d after period end
